qTPI: 一个准毒性概率间隔设计,用于具有多级毒性的第一阶段试验
Haodong Ling1, Haolun Shi2, Nan Yuan1
1School of Data Science, Fudan University, Shanghai, China.
Statistical methods in medical research
|June 6, 2023
概括
这项研究为I期临床试验引入了一种新的准毒性概率区间 (qTPI) 设计. 在药物开发过程中,qTPI设计提高了评估多级毒性的安全性和准确性.
科学领域:
- 临床试验的设计
- 生物统计学 生物统计学
- 药理学 药理学是指药理学的学科.
背景情况:
- 美国国家癌症研究所对不良事件的常用术语标准 (Common Terminology Criteria for Adverse Events) 已经推动了药物开发.
- 一期试验越来越多地收集多级毒性数据,需要先进的统计设计.
- 现有的设计往往缺乏透明度和对细微的毒性数据的适当处理.
研究的目的:
- 为多级毒性提出一种新,透明和统计学上合理的I期临床试验设计.
- 引入准毒性概率区间 (qTPI) 设计,整合一个准连续的毒性测量.
- 提高药物开发早期阶段剂量选择的安全性,准确性和可靠性.
主要方法:
- 在贝叶斯框架内开发了准毒性概率区间 (qTPI) 设计.
- 纳入了近连续毒性概率 (qTP) 测量,通过严重程度重量矩阵绘制多级毒性.
- 使用累积的患者数据不断更新剂量毒性曲线.
主要成果:
- 数字模拟表明,与二进制毒性设计相比,qTPI设计提供了更高的安全性,准确性和可靠性.
- qTPI设计简化了参数诱导,避免了多个假设队列的需要.
- 软组织肉瘤试验的示例应用显示了有效的患者对患者的剂量分配.
结论:
- qTPI设计为具有多级毒性的第一阶段试验提供了强大的和高效的统计框架.
- 这种方法提高了瘤学中剂量检测研究的精度和安全性.
- qTPI代表了临床试验方法的重大进步,用于评估药物的安全性和有效性.
相关概念视频
01:13Therapeutic Index
4.4K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.4K
01:11Clinical Trials: Overview
3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
150
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
150
01:19Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
248
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
248
01:16Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
01:22Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
272
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
272